We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current INM market cap is 1.93M. The company's latest EPS is USD -11.5080 and P/E is -0.25.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.24M | 1.17M | 1.28M | 1.27M | 1.11M |
| Operating Income | -1.53M | -2.06M | -2.27M | -1.75M | -2.21M |
| Net Income | -1.48M | -1.72M | -1.94M | -1.68M | -2.58M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 1.09M | 4.14M | 4.6M |
| Operating Income | -9.15M | -9.94M | -17.27M | -8.38M | -8.14M |
| Net Income | -8.94M | -10.2M | -18.6M | -7.95M | -7.68M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 15.26M | 13.36M | 11.82M | 10.47M | 8.5M |
| Total Liabilities | 2.48M | 2.25M | 2.62M | 2.07M | 2.32M |
| Total Equity | 12.77M | 11.11M | 9.21M | 8.4M | 6.18M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.8M | 9.78M | 12.79M | 14.11M | 11.82M |
| Total Liabilities | 1.93M | 2.41M | 3.71M | 2.02M | 2.62M |
| Total Equity | 5.88M | 7.38M | 9.08M | 12.09M | 9.21M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.02M | -5.96M | -6.99M | -1.83M | -4.33M |
| Investing | -9k | -9k | -9k | N/A | N/A |
| Financing | 4.65M | 4.65M | 4.65M | 838k | 1.18M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.38M | -9.79M | -15.58M | -7.28M | -6.99M |
| Investing | 3.79M | -2k | -673k | -662k | -9k |
| Financing | -31k | 10.86M | 15.07M | 10.68M | 4.65M |
| Market Cap | 1.93M |
| Price to Earnings Ratio | -0.25 |
| Price to Sales Ratio | 0.42 |
| Price to Cash Ratio | 0.29 |
| Price to Book Ratio | 0.21 |
| Dividend Yield | - |
| Shares Outstanding | 667.01k |
| Average Volume (1 week) | 50.42k |
| Average Volume (1 Month) | 75.28k |
| 52 Week Change | -65.60% |
| 52 Week High | 15.576 |
| 52 Week Low | 2.414 |
| Spread (Intraday) | 0.58 (18.24%) |
| Company Name | InMed Pharmaceuticals Inc |
| Address |
340 - 200 granville street vancouver, british columbia V6C 1S4 |
| Website | https://www.inmedpharma.com |
| Industry | security systems service (7382) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
